Search
for
Sort by
Research 121–150 of 877
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Eyebrow and Eyelash Transplantation Using Chalazion Forceps (Dr. Min’s Method) and Importance of Post-Transplant Recovery in Hair Restoration
- Role of microneedling in treatment of alopecia areata
- Enhancing hair regrowth in Alopecia areata: the power duo of CO2 fractional laser and Bimatoprost
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in androgenic alopecia
- Nonscarring Alopecias
- Alopecia areata: Clinical presentation, diagnosis, and unusual cases
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Baricitinib: A Review in Severe Alopecia Areata
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata
- Long-term hair loss associated with brentuximab vedotin–containing chemotherapy and its psychosocial impact: A retrospective observational study conducted at the Royal Marsden Hospital.
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- A NEW COMBINATION OF KNOWN AGENTS FOR TREATMENT OF ALOPECIA AREATA: A CASE-SERIES STUDY.
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Advancements in non-laser energy-based devices in trichology: A comprehensive review
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1